Quantification of quality of life improvement after appropriate symptoms control in cancer patients with breakthrough pain: A four-week follow-up study in a palliative care unit

Viejo, Miguel Ángel Núñez; Manrique, Carmen Areses; Rey, Leticia Iglesias; Rey, Antonio Iglesias; López, Antonio Javier Jiménez; Álvarez, Ana Cabezón; López, Begoña Soler

doi:10.15761/tim.1000198

Trends Med

2019

DOI: 10.15761/tim.1000198

|View full text |Cite

Quantification of quality of life improvement after appropriate symptoms control in cancer patients with breakthrough pain: A four-week follow-up study in a palliative care unit

Miguel Ángel Núñez Viejo¹,

Carmen Areses Manrique²,

Leticia Iglesias Rey³

et al.

Abstract: El copyright y otros derechos de propiedad intelectual de este documento pertenecen al Ministerio de Sani dad, Política Social e Igualdad. Se autoriza a las organizaciones de atención sanitaria a reproducir total o par cialmente para uso no comercial, siempre que se cite el nombre completo del documento, año e institución.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2020

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 45 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Assessment of symptoms, quality of life and associated costs in a one-month follow-up of cancer patients with breakthrough pain: The IMDI Study

Pérez¹,

Jiménez-López²,

Sanz-Yagüe³

et al. 2020

Open J Pain Med

View full text Add to dashboard Cite

Purpose: Breakthrough Pain (BTP) observed in up to 66% of cancer patients, is more common in patients with advanced cancer stages and is usually associated with a poor prognosis. The objective of this study was to evaluate the quality of life and control of associated symptoms of cancer patients with breakthrough pain (BTP) after a one-month follow-up in pain and palliative care units and measure the associated cost savings after our intervention. Methods/patients: A one-month observational prospective study was designed. Eight Spanish pain units, eight palliative care units, and one oncology department participated. On baseline and one-month visit, the Edmonton Symptoms Assessment Scale (ESAS), Brief Pain Inventory (BPI) and the quality of life (EORTC QLQ-C30, version 3) were assessed. The direct medical and non-medical costs fi xed and variable and the indirect costs of the patient and the caregivers were evaluated and published previously. Factors related to cost and quality of life, were identifi ed using Linear Generalized Models (LGM) type gamma and logistic link. Participants were oncologic patients with BTP, older than 18 years, with controlled background pain. Results: A total of 152 patients with a mean age of 66.8 years (95% CI 64.8-68.8), and 65.8% males were included. All symptoms (ESAS) were signifi cantly improved (p<0.05) from baseline to one month of follow-up. BPI dimensions and all functional and symptoms dimensions of EORTC QLQ-30 were also improved in one month (p<0.01). An improvement in EORTC QLQ-30 global health status-quality of life was associated with a reduction in overall BTP costs. Conclusions: Cancer patients improved their quality of life and cancer associated symptoms in only one month of treatment in pain and palliative care units, and this improvement leads to signifi cant BTP cost savings.

show abstract

Assessment of symptoms, quality of life and associated costs in a one-month follow-up of cancer patients with breakthrough pain: The IMDI Study

Pérez¹,

Jiménez-López²,

Sanz-Yagüe³

et al. 2020

Open J Pain Med

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Quantification of quality of life improvement after appropriate symptoms control in cancer patients with breakthrough pain: A four-week follow-up study in a palliative care unit

Cited by 1 publication

References 45 publications

Assessment of symptoms, quality of life and associated costs in a one-month follow-up of cancer patients with breakthrough pain: The IMDI Study

Assessment of symptoms, quality of life and associated costs in a one-month follow-up of cancer patients with breakthrough pain: The IMDI Study

Contact Info

Product

Resources

About